Viscosupplementation System Market is anticipated to grow at a CAGR of around 8.6% during the forecast period. The key factors that driving market growth include the increasing prevalence of osteoarthritis across the globe coupled with the rising demand for viscosupplementation. For instance, according to Centre for Disease Control and Prevention estimation of 1 in 4 (or 54.4 million), Although there are more than 100 types of arthritis, osteoarthritis (OA) is the most common, affecting 32.5 million adults in the US. Adults in the US suffer from arthritis, with the number expected to rise to 78 million by 2040. Further, improvement in healthcare infrastructure and providence of medical assistance also drive the market. For instance, according to Commonwealth Fund, in 2018, almost 92% of the population got medical insurance coverage in the US and almost 55% population was covered under Employer-sponsored health insurance.
Moreover, significant advancement in the viscosupplementation by the major players in the market also propel the growth of the market. For instance, in January 2019, OrthogenRx introduced TriVisc, a sodium hyaluronate for the treatment of knee osteoarthritis in a three-injection regimen in the US. TriVisc is the least expensive in terms of price and this launch will be allowing OrthogenRx to stay the course in providing healthcare practitioners and patients with reasonable and reliable pricing for all goods.
To Request a Sample of our Report on Viscosupplementation System Market: https://www.omrglobal.com/request-sample/viscosupplementation-market
Market Coverage
- The market number available for – 2022-2029
- Base year- 2022
- Forecast period- 2023-2029
Segment Covered-
- By Product
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- Anika Therapeutics, Inc., LG chem., Smith & Nephew Plc, Seikagaku Corp., Lifecore Biomedical, LLC, Sanofi S.A., Zimmer Biomet Holdings, Inc., and others
Viscosupplementation Market Report Segment
By Product
- Single-Injection
- Three-Injection
- Five-Injection
By Application
- Knee
- Hip
- Ankle
- Others
A full Report of Viscosupplementation System Market is Available at: https://www.omrglobal.com/industry-reports/viscosupplementation-market
Viscosupplementation Market Report Segment by Region
North America
United States
Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Anika Therapeutics, Inc.
- Ferring B.V.
- Fidia Farmaceutici S.p.A
- Johnson & Johnson Services, Inc.
- KalVista Pharmaceuticals, Inc.
- LG Chem (Life Sciences)
- Lifecore Biomedical, LLC
- Maxigen Biotech, Inc.
- Pharmascience Inc.(PendoPharm)
- Regen Lab SA
- Sanofi S.A.
- Seikagaku Corp.
- Shanghai Haohai Biological Technology Co., Ltd.
- Smith & Nephew PLC
- Stellar Pharmaceuticals, Inc.
- Stryker Corp.
- Swiss Biomed Orthopaedics AG
- Virchow Biotech Pvt. Ltd.
- Zimmer Biomet Holdings, Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/viscosupplementation-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
